Category Venues

Health R&D Experts Conclude Meeting With Few Details But Signal More Openness

An expert body under the World Health Organization tasked with finding innovative solutions for financing research for needed medicines concluded its second official meeting Wednesday, working on a process to analyse possible mechanisms. The WHO afterward appeared to address concerns – which included a civil society letter – by insisting there would be more transparency in the negotiating process, but did not provide assurance that potential conflicts of interest would be properly addressed.

European Patent System, Court Top Priority Under Swedish EU Presidency

COPENHAGEN - A top priority for Sweden as it takes over the EU presidency on 1 July is to boost negotiations on a Community patent system and a European Patent Court, the government says. Its work programme also emphasises the need for "effective protection of intellectual property rights" and lists a conference on enforcement. Officials, however, deny that enforcement is among the presidency's main IP focus. And the Pirate Party is concerned.

Global Legislative Reform Could Unlock Benefits Of GIs, Advocates Say

TERUEL, SPAIN - Geographical indications (GIs) are in the interest of both producers and consumers as they provide a tool for sustainable economic growth and offer a guarantee of quality, concluded a high-level meeting of GI proponents last week. However, with shortcomings in the international framework and a lack of consensus on GIs, countries have been trying to find legal ways to address the issue.

WIPO Work Likely To Continue On Traditional Knowledge, But How?

An intergovernmental committee considering ways to protect kinds of knowledge that predate - and may not fit into - the current intellectual property system picked up this week after a chaotic round of negotiations failed to make any progress at the last meeting. Meanwhile, some indigenous groups, in whose traditions rest much of this knowledge, continue a push for stronger representation at the committee.

WHO R&D Financing Group To Parse New Ideas, Look For Ways Forward

Perhaps the single most critical issue to resolve in addressing neglected diseases is how to ensure there is money to pay for research and clinical trials, even when the consumer demand is small and its constituents poor. A group of experts under the auspices of the World Health Organization this week is attempting to address the problem.